SCP Vitalife Partners (Israel) II, L.P., 10% Owner at Recro Pharma, Inc. (REPH), sold 6,399 shares at $8.01 ($51K) on 2017-03-15, disclosed to the SEC on 2017-03-16.
Open-market sale of $51k REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| REPH | SELL | 2018-01-08 | $14K | — | Filing → |
| REPH | SELL | 2018-01-04 | $230K | — | Filing → |
| REPH | SELL | 2018-01-02 | $56K | — | Filing → |